Biotest Pharmaceuticals - Therapy Business Unit's Unit Acquisition

Biotest Pharmaceuticals - Therapy Business Unit raised a round of funding on June 06, 2017. Investors include ADMA Biologics.

Biotest Pharmaceuticals, a wholly-owned subsidiary of Biotest AG, specializes in the collection of source plasma and owns and manages plasmapheresis centers across the United States.…

Articles about Biotest Pharmaceuticals - Therapy Business Unit's Unit Acquisition: